Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review

Wound healing is a well-tuned biological process, which is achieved via consecutive and overlapping phases including hemostasis, inflammatory-related events, cell proliferation and tissue remodeling. Several factors can impair wound healing such as oxygenation defects, aging, and stress as well as deleterious health conditions such as infection, diabetes, alcohol overuse, smoking and impaired nutritional status. Growing evidence suggests that reactive oxygen species (ROS) are crucial regulators of several phases of healing processes. ROS are centrally involved in all wound healing processes as low concentrations of ROS generation are required for the fight against invading microorganisms and cell survival signaling. Excessive production of ROS or impaired ROS detoxification causes oxidative damage, which is the main cause of non-healing chronic wounds. In this context, experimental and clinical studies have revealed that antioxidant and anti-inflammatory strategies have proven beneficial in the non-healing state. Among available antioxidant strategies, treatments using mitochondrial-targeted antioxidants are of particular interest. Specifically, mitochondrial-targeted peptides such as elamipretide have the potential to mitigate mitochondrial dysfunction and aberrant inflammatory response through activation of nucleotide-binding oligomerization domain (NOD)-like family receptors, such as the pyrin domain containing 3 (NLRP3) inflammasome, nuclear factor-kappa B (NF-κB) signaling pathway inhibition, and nuclear factor (erythroid-derived 2)-like 2 (Nrf2).

[1]  H. Griffiths,et al.  The dual role of Reactive Oxygen Species in autoimmune and inflammatory diseases: evidence from preclinical models , 2018, Free radical biology & medicine.

[2]  J. Sibilia,et al.  Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation , 2018, Front. Immunol..

[3]  W. Weaver,et al.  Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy , 2018, Neurology.

[4]  K. Griendling,et al.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling. , 2018, Circulation research.

[5]  Hiroyasu Ito,et al.  Activation of NLRP3 signalling accelerates skin wound healing , 2018, Experimental dermatology.

[6]  D. Leavesley,et al.  Xanthine Oxidoreductase: A Novel Therapeutic Target for the Treatment of Chronic Wounds? , 2017, Advances in wound care.

[7]  A. Nurden The biology of the platelet with special reference to inflammation, wound healing and immunity. , 2018, Frontiers in bioscience.

[8]  E. Yow,et al.  Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide , 2017, Circulation. Heart failure.

[9]  T. Kyriakides,et al.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition. , 2017, Antioxidants & redox signaling.

[10]  P. Guillausseau,et al.  Activation of the receptor for advanced glycation end products and consequences on health. , 2017, Diabetes & metabolic syndrome.

[11]  M. Pepper,et al.  Reactive Oxygen Species and NOX Enzymes Are Emerging as Key Players in Cutaneous Wound Repair , 2017, International journal of molecular sciences.

[12]  Piul S. Rabbani,et al.  The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus , 2017, Journal of diabetes research.

[13]  B. Chernyak,et al.  Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice , 2017, Oxidative medicine and cellular longevity.

[14]  R. Z. Murray,et al.  Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing , 2017, International journal of molecular sciences.

[15]  R. Neviere,et al.  Kidney, heart and brain: three organs targeted by ageing and glycation. , 2017, Clinical science.

[16]  P. Schumacker,et al.  Redox signaling during hypoxia in mammalian cells , 2017, Redox biology.

[17]  Y. Pan,et al.  Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor‐3 and downregulates nuclear factor‐κB in diabetic patients with foot ulcerations , 2017, Diabetes/metabolism research and reviews.

[18]  Shuliang Lu,et al.  Hydrogen Peroxide: A Potential Wound Therapeutic Target , 2017, Medical Principles and Practice.

[19]  B. Brüne,et al.  Mitochondrial composition and function under the control of hypoxia , 2017, Redox biology.

[20]  S. Yamagishi,et al.  Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory , 2017, Journal of diabetes.

[21]  J. Cooke,et al.  Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS‐modulating technologies for augmentation of the healing process , 2017, International wound journal.

[22]  Y. Chai,et al.  NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages , 2017, Journal of diabetes research.

[23]  A. Galandáková,et al.  Models for the study of skin wound healing. The role of Nrf2 and NF-κB. , 2017, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[24]  Jin Han,et al.  Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders. , 2017, Advances in experimental medicine and biology.

[25]  P. Reddy,et al.  Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease. , 2017, Progress in molecular biology and translational science.

[26]  P. Moortgat,et al.  The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review , 2016, Scars, burns & healing.

[27]  J. Janis,et al.  Wound Healing: Part I. Basic Science , 2016, Plastic and reconstructive surgery.

[28]  K. Krause,et al.  NADPH oxidase 4 deficiency leads to impaired wound repair and reduced dityrosine-crosslinking, but does not affect myofibroblast formation. , 2016, Free radical biology & medicine.

[29]  Lei Wang,et al.  Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions , 2016, Glycoconjugate Journal.

[30]  M. Brownlee,et al.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. , 2016, Circulation research.

[31]  M. Ståhle,et al.  Transition from inflammation to proliferation: a critical step during wound healing , 2016, Cellular and Molecular Life Sciences.

[32]  P. Schumacker,et al.  O2 sensing, mitochondria and ROS signaling: The fog is lifting. , 2016, Molecular aspects of medicine.

[33]  A. Chandra,et al.  Biomarkers for wound healing and their evaluation. , 2016, Journal of wound care.

[34]  E. Caterson,et al.  Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. , 2014, Advances in wound care.

[35]  Piul S. Rabbani,et al.  Restoration of Nrf2 Signaling Normalizes the Regenerative Niche , 2015, Diabetes.

[36]  K. Jandeleit-Dahm,et al.  Linking RAGE and Nox in diabetic micro- and macrovascular complications. , 2015, Diabetes & metabolism.

[37]  D. Baker,et al.  The innate immune system, toll-like receptors and dermal wound healing: A review. , 2015, Vascular pharmacology.

[38]  Ş. Coşkun-Cevher,et al.  A bioactive molecule in a complex wound healing process: platelet‐derived growth factor , 2015, International journal of dermatology.

[39]  A. Poole,et al.  Platelet secretion: From haemostasis to wound healing and beyond , 2015, Blood reviews.

[40]  M. Longaker,et al.  Emerging drugs for the treatment of wound healing , 2015, Expert opinion on emerging drugs.

[41]  T. Koh,et al.  Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing , 2015, PloS one.

[42]  Andrew L. Weinstein,et al.  Normalizing dysfunctional purine metabolism accelerates diabetic wound healing , 2015, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[43]  Y. Tokura,et al.  Attempts to accelerate wound healing. , 2014, Journal of dermatological science.

[44]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[45]  M. Banerjee,et al.  Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus☆ , 2013, Redox biology.

[46]  Donna D. Zhang,et al.  The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV , 2013, Redox biology.

[47]  P. Bainbridge,et al.  Wound healing and the role of fibroblasts. , 2013, Journal of wound care.

[48]  J. Ha,et al.  Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines , 2013, BMC Medicine.

[49]  J. Ather,et al.  Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status. , 2013, Free radical biology & medicine.

[50]  J. Rosado,et al.  Molecular interplay between platelets and the vascular wall in thrombosis and hemostasis. , 2013, Current vascular pharmacology.

[51]  N. Žarković,et al.  Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation , 2013, Free radical research.

[52]  C. Artlett Inflammasomes in wound healing and fibrosis , 2013, The Journal of pathology.

[53]  P. Galéra,et al.  NF-κB accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a -112/-61-bp region of the COL1A1 promoter in human skin fibroblasts. , 2012, The Journal of investigative dermatology.

[54]  Yves Bayon,et al.  Reactive oxygen species (ROS)--a family of fate deciding molecules pivotal in constructive inflammation and wound healing. , 2012, European cells & materials.

[55]  Michael R Hamblin,et al.  Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery. , 2012, Advances in skin & wound care.

[56]  T. Guzik,et al.  Targeting NADPH oxidases in vascular pharmacology. , 2012, Vascular pharmacology.

[57]  F. Al-Mulla,et al.  A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes. , 2011, American journal of physiology. Endocrinology and metabolism.

[58]  D. Gutterman,et al.  ROS-induced ROS release in vascular biology: redox-redox signaling. , 2011, American journal of physiology. Heart and circulatory physiology.

[59]  G. Dusting,et al.  NADPH Oxidase-Mediated Redox Signaling: Roles in Cellular Stress Response, Stress Tolerance, and Tissue Repair , 2011, Pharmacological Reviews.

[60]  R. Sivamani,et al.  Antioxidant Therapies for Wound Healing: A Clinical Guide to Currently Commercially Available Products , 2011, Skin Pharmacology and Physiology.

[61]  P. Pelicci,et al.  The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing , 2010, Diabetes.

[62]  S. Kondo,et al.  Spontaneous skin damage and delayed wound healing in SOD1-deficient mice , 2010, Molecular and Cellular Biochemistry.

[63]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[64]  A. Fukamizu,et al.  Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[65]  M. Peppa,et al.  Advanced glycoxidation products and impaired diabetic wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[66]  Chandan K Sen,et al.  Wound healing essentials: Let there be oxygen , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[67]  C. Sen,et al.  Redox signals in wound healing. , 2008, Biochimica et biophysica acta.

[68]  Shuliang Lu,et al.  Effects of Extracellular Matrix Glycosylation on Proliferation and Apoptosis of Human Dermal Fibroblasts Via the Receptor for Advanced Glycosylated End Products , 2008, The American Journal of dermatopathology.

[69]  Matthias Schäfer,et al.  Oxidative stress in normal and impaired wound repair. , 2008, Pharmacological research.

[70]  M. Huijberts,et al.  Advanced glycation end products and diabetic foot disease , 2008, Diabetes/metabolism research and reviews.

[71]  G. Siegal,et al.  Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism , 2007, The Journal of experimental medicine.

[72]  Alex F Chen,et al.  Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice , 2004, Circulation.

[73]  A. Schmidt,et al.  Use of Topical sRAGE in Diabetic Wounds Increases Neovascularization and Granulation Tissue Formation , 2004, Annals of plastic surgery.

[74]  M. Peppa,et al.  Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.

[75]  T. Kislinger,et al.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.